You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

List of Excipients in API SIROLIMUS


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing SIROLIMUS

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc RAPAMUNE sirolimus 0008-1030 POLYSORBATE 80
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc RAPAMUNE sirolimus 0008-1030 PROPYLENE GLYCOL
Greenstone LLC SIROLIMUS sirolimus 59762-1001 .ALPHA.-TOCOPHEROL ACETATE
Greenstone LLC SIROLIMUS sirolimus 59762-1001 CALCIUM SULFATE
Greenstone LLC SIROLIMUS sirolimus 59762-1001 CARNAUBA WAX
Greenstone LLC SIROLIMUS sirolimus 59762-1001 CELLULOSE, MICROCRYSTALLINE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing SIROLIMUS

Company Ingredient NDC Excipient
Major Pharmaceuticals sirolimus 0904-7147 .ALPHA.-TOCOPHEROL, DL-
Major Pharmaceuticals sirolimus 0904-7147 CELLULOSE, MICROCRYSTALLINE
Major Pharmaceuticals sirolimus 0904-7147 CROSCARMELLOSE SODIUM
Major Pharmaceuticals sirolimus 0904-7147 EDETATE DISODIUM
Major Pharmaceuticals sirolimus 0904-7147 GLYCERYL DIBEHENATE
Major Pharmaceuticals sirolimus 0904-7147 HYPROMELLOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for SIROLIMUS

Excipient focus: .ALPHA.-TOCOPHEROL

Excipient focus: .ALPHA.-TOCOPHEROL ACETATE

Excipient focus: .ALPHA.-TOCOPHEROL, DL-

Excipient focus: ALBUMIN HUMAN

Excipient focus: ALCOHOL

Excipient focus: ALPHA-TOCOPHEROL

Excipient focus: ALPHA-TOCOPHEROL ACETATE

Excipient focus: AMMONIA

Excipient focus: ASCORBYL PALMITATE

Excipient focus: CALCIUM SULFATE

Excipient focus: CARBOMER HOMOPOLYMER TYPE C

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIACETYLATED MONOGLYCERIDES

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: GLYCERYL MONO- AND DIPALMITOSTEARATE

Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE

Excipient focus: GLYCERYL MONOOLEATE

Excipient focus: GLYCERYL OLEATE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: LYSOPHOSPHATIDYLCHOLINE, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: NITROGEN

Excipient focus: PHOSPHATIDYLCHOLINE, SOYBEAN

Excipient focus: POLOXAMER 188

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 20000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SOY ACID

Excipient focus: SOYBEAN PHOSPHATIDYLCHOLINE

Excipient focus: SUCROSE

Excipient focus: SUNFLOWER OIL MONO/DIGLYCERIDES

Excipient focus: SUNFLOWER SEED OIL GLYCERETH-8 ESTERS

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TOCOPHEROL

Excipient focus: TROLAMINE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links